Assessment of chlorpromazine as radiation sensitizer and protector

Indian Journal of Cancer

Volumn 33, Issue 4, 1996, Pages 195-200

  Huilgol, Nagraj G ^b   Chatterjee, Neela ^b   Singh, B B ^a  

^a BARC

^b DR BALABHAI NANAVATI HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; RADIOPROTECTIVE AGENT; RADIOSENSITIZING AGENT;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRALESIONAL DRUG ADMINISTRATION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR;

CARCINOMA, SQUAMOUS CELL; CHLORPROMAZINE; FEMALE; HUMANS; INJECTIONS, INTRALESIONAL; RADIATION-PROTECTIVE AGENTS; RADIATION-SENSITIZING AGENTS; UTERINE CERVICAL NEOPLASMS;

EID: 0030325552     PISSN: 0019509X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Abe K., Sekizawa T. and Kogure K. : Biphasic effects of chlorpromazinc on cell viability in ncuroblastoma cell line. Neuroscience Letters 1986: 71; 335-339.
2. Bush R. S. : The significance of anemia in clinical radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 1986 : 12; 2047-2050.
3. Cann J. R.and Hinman N. D. Interaction of chlorpromazine with brain microtubule subunit protein. Molecular Pharmacology 1975 : 11 ; 256-227.
4. +2 regulation Proc. Natl. Acad. Sci. USA 1977 : 74; 129-133.
5. Eiffel P. J. M., Whartan M. T. and Oswald M. J. : The influence of tumour size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int. J. Radiat Oncol. Biol. Phys., 1994 : Vol 29, No. 1; 9-16.
6. Hatt W.N.and Lee G. L. : Charracteristics of the cytotoxic effects of the phenothiazine class of calmodulin antagonists. Biochemical Pharmacology 1985 : Vol. 32, No 22; 3973-78.
7. Henk J. M. : Docs hyperbaric oxygen have a future in radiation therapy? Int. J. Radiat. Oncol. Biol. Phys. 1981 : 1125-1128.
8. Kerrick Wal, Hoar P. E., Cassidy P. S. : Calcium activated tension. The role of myosin light chain phosphorylation Fed. Proc. 1980 : 39; 1558-1563.
9. Levin R. M., Weiss B : Ca+2 blocker effects of CPZ is crucial in understanding anti proliferative potential as well as protective. Molecular Pharmacology, 1976 : 12; 581.
10. Maniar H. S. and Singh B. B. : Radiosensitivity and radioprotective effects of phenothiazines. Indian Journal of Experimental Biology 1985 : Vol. 23; 100-102.
11. Morton D. L., Hunt K. K., Bauer R. L. Lee J. D. : Clinical applications using intralesional therapy of cancer. Ed. V. D. DeVitn Jr.,S.Hellman&S.A.Rosenberg, J. B. Lippincot Company, 1991.
12. Nokano M., Sugioko K., Nakano H., : Takay C. and Iraba H. : Generation of electrically excited species during enzymatic oxidation of CPZ and related compounds. Biochem Biophys. Res. Commn 1985 : 130; 952-956.
13. Ogletree M. L. : Overview of physiological and pathophysiological effects of thromboxane A2. Fed. Proc 1987 : 46; 133-138.
14. Zilberman Y., Gutman Y. and Koren R. : The effects of verapanil, lanthanum and local anesthetics on scrotinim release from rabbit platelets. Biochem. Biophys. Acta 1982 : 691; 106-114.